Concord Story

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;'>CM</div>
CCM -- USA Stock  

USD 3.44  0.04  1.15%

The stock continues to experience an active upward rally. Concord Medical Asset Turnover is relatively stable at the moment as compared to the past year. The company's current value of Asset Turnover is estimated at 0.0462. Current Ratio is expected to hike to 0.46 this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (267.8 M). While some baby boomers are getting worried about healthcare space, it is reasonable to summarize Concord Medical Services as an investment alternative. We will check if the company can maintain a respectable level of debt while minimizing operating losses.
Published over a month ago
View all stories for Concord Medical | View All Stories
How much will Concord Medical owe in January?
Concord Medical Serv has 161.28 M in debt with debt to equity (D/E) ratio of 0.94, which is OK given its current industry classification. The entity has a current ratio of 1.15, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. The company has Net Profit Margin of (162.61) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average.
Concord Medical financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures the total debt position of Concord Medical, including all of Concord Medical's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Concord Medical assets, the company is considered highly leveraged. Understanding the composition and structure of overall Concord Medical debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business is and if it is worth investing in it. Please read more on our technical analysis page.

Understanding Concord Total Liabilities

Concord Medical Serv liabilities are broken down into two parts on the balance sheet. These are short-term (or current) obligations and long-term debt. Concord Medical Serv has to fulfill its short-term liabilities in this reporting year and should be no more than 12 months old. Long-term debt, on the other hand, is anything beyond the 12-month payment timeframe. Common short-term liabilities found on Concord Medical balance sheet include debt obligations and money owed to different Concord Medical vendors, workers, and loan providers. Below is the chart of Concord short long-term liabilities accounts currently reported on its balance sheet.
You can use Concord Medical Services financial leverage analysis tool to get a better grip on understanding its financial position

How important is Concord Medical's Liquidity

Concord Medical financial leverage refers to using borrowed capital as a funding source to finance Concord Medical Services ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Concord Medical financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Concord Medical's total debt and its cash.

A Deeper look at Concord

The new price hike of Concord Medical Serv could raise concerns from stakeholders as the firm it trading at a share price of 2.40 on 177,300 in volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in January. The stock standard deviation of daily returns for 30 days investing horizon is currently 6.01. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Concord Medical partners.

Liabilities Breakdown

Tax Liabilities
778.9 M
Current Liabilities
1.9 B
Long-Term Liabilities
Deposit Liabilities4.86 Million
Total Liabilities2.13 Billion
Current Liabilities778.85 Million
Long-Term Liabilities1.92 Billion
Tax Liabilities146.68 Million

Concord Medical implied volatility may change after the hike

New mean deviation is at 3.07. Concord Medical Services exhibits very low volatility with skewness of 1.46 and kurtosis of 6.83. However, we advise investors to further study Concord Medical Services technical indicators to make sure all market info is available and is reliable.

Our Final Take On Concord Medical

While some other firms within the medical care facilities industry are still a little expensive, even after the recent corrections, Concord Medical may offer a potential longer-term growth to stakeholders. While some stakeholders may not share our view, we believe that right now is not a good time to increase your holdings in Concord. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Concord Medical.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Concord Medical Services. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com